Skip to main content

Want a detailed portfolio tracker?

Nkarta (NKTX) P/E (2020 - 2026)

Nkarta (NKTX) P/E from Jul 10, 2020 to Jul 21, 2026. The TTM Nkarta (NKTX) P/E is -1.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nkarta (NKTX)

YearP/EChange
2026-1.83+40.49%
2025-1.30-4.36%
2024-1.36-50.22%
2023-2.73+21.54%
2022-2.25-45.15%
2021-4.10-80.74%
2020-21.29N/A

Comparison Nkarta (NKTX) P/E with competitors

Nkarta (NKTX) P/E is -1.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.24%
ENLVEnlivex Ltd0.07-104.09%
FGENFibroGen Inc0.24-113.13%
CHRSCoherus Biosciences Inc0.85-146.42%
FBIOFortress Biotech Inc0.95-151.91%
ORMPOramed Pharmaceuticals Inc1.50-182.22%
AGENAgenus Inc3.01-264.63%
INVAInnoviva Inc3.15-272.53%
VXRTVaxart Inc3.55-294.17%
CRMDCorMedix Inc3.63-298.48%
CVACCureVac N.V.4.45-343.18%
GLPGGalapagos NV4.86-365.79%
SRPTSarepta Therapeutics Inc4.88-367.06%
ABEOAbeona Therapeutics Inc5.39-394.70%
ABUSArbutus Biopharma Corp5.60-406.09%
ZVRAZevra Therapeutics Inc5.89-422.04%
SPROSpero Therapeutics Inc6.23-440.70%
CGENCompugen Ltd6.31-445.38%
RIGLRigel Pharmaceuticals6.87-475.91%
SLXNSilexion Therapeutics Corp7.30-499.10%
OMEROmeros Corporation9.26-606.46%
AUPHAurinia Pharmaceuticals Inc9.58-624.31%
PLXProtalix BioTherapeutics Inc10.89-695.75%
ACADAcadia Pharmaceuticals Inc11.73-741.56%
TBPHTheravance Biopharma Inc12.26-770.75%
ADMAAdma Biologics Inc12.42-779.29%
HRMYHarmony Biosciences Holdings Inc13.82-855.98%
SABSSAB Biotherapeutics Inc14.14-873.27%
NAGENiagen Bioscience Inc14.82-910.57%
INCYIncyte Corp15.82-965.51%
REGNRegeneron Pharmaceuticals Inc15.86-967.38%
PBYIPuma Biotechnology Inc17.32-1047.19%
CPRXCatalyst Pharmaceuticals Inc17.44-1053.95%
EXELExelixis Inc17.54-1059.35%
TGTXTG Therapeutics Inc18.97-1137.47%
MDXGMimedx Group Inc20.55-1224.25%
XOMAXOMA Royalty Corp22.87-1351.31%
ARGXArgen X SE24.30-1429.17%
CTMXCytomX Therapeutics Inc24.82-1457.78%
XOMAOXOMA Royalty Corp25.34-1486.43%
HALOHalozyme Therapeutics Inc25.62-1501.69%
XOMAPXOMA Royalty Corp25.67-1504.22%
VRTXVertex Pharmaceuticals Inc27.99-1631.39%
RPRXRoyalty Pharma plc - Class A28.69-1669.28%
SLNOSoleno Therapeutics Inc29.02-1687.22%
ASNDAscendis Pharma A/S30.09-1745.76%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2173.89%
APLSApellis Pharmaceuticals Inc39.02-2234.57%
BMRNBiomarin Pharmaceutical Inc42.21-2409.10%
KRYSKrystal Biotech Inc45.34-2580.41%
ONCBeiGene Ltd69.54-3904.05%
PHARPharming Group N.V.75.03-4204.10%
TECHBio-Techne Corp101.96-5677.40%
VCELVericel Corp109.92-6112.99%
ALNYAlnylam Pharmaceuticals Inc117.96-6553.01%
GMABGenmab140.29-7774.29%
TLXTelix Pharmaceuticals Ltd162.15-8970.20%
CORTCorcept Therapeutics Inc212.86-11743.88%